Research ArticleOriginal Research

Risk of Adverse Health Outcomes with Increasing Duration and Regularity of Opioid Therapy

Leonard J. Paulozzi, Kun Zhang, Christopher M. Jones and Karin A. Mack
The Journal of the American Board of Family Medicine May 2014, 27 (3) 329-338; DOI: https://doi.org/10.3122/jabfm.2014.03.130290

References

  1. 1.↵
    1. Compton WM,
    2. Volkow ND
    . Major increases in opioid analgesics abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006;81:103–7.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Kenan K,
    2. Mack K,
    3. Paulozzi L
    . Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010. Open Med 2012;6(2):e41.
    OpenUrlPubMed
  3. 3.↵
    The use of medicines in the United States: review of 2011. Parsippany, NJ: IMS Institute for Healthcare Informatics; 2012. Available from: http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_Report_2011.pdf. Accessed March 11, 2014.
  4. 4.↵
    1. Volkow N,
    2. McLellan T,
    3. Cotto J
    . Characteristics of opioid prescriptions in 2009. JAMA 2011;305:1299–301.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Roe CM,
    2. McNamara AM,
    3. Motheral BR
    . Gender- and age-related prescription drug use patterns. Ann Pharmacother 2002;36:30–9.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Boudreau D,
    2. Von Korff M,
    3. Rutter CM,
    4. et al
    . Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009;18:1166–75.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Prescription controlled substance dispensing in Oregon: October 1, 2011–March 31, 2012. Schedules II–IV medications dispensed in Oregon, statewide. Portland: Oregon Health Authority; 2012. Available from: http://www.orpdmp.com/orpdmpfiles/PDF_Files/Reports/Statewide_10.01.11_to_03.31.12.pdf. Accessed March 11, 2014.
  8. 8.↵
    Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011;60:1487–92.
    OpenUrlPubMed
  9. 9.↵
    1. Sullivan MD,
    2. Edlung MJ,
    3. Fan M,
    4. DeVries A,
    5. Braden JB,
    6. Martin BC
    . Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008;138:440–9.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Hudson T,
    2. Edlung M,
    3. Steffick D,
    4. Tripathi S,
    5. Sullivan M
    . Epidemiology of regular prescribed opioid use: results from a national, population-based survey. J Pain Symptom Manage 2008;36:280–8.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Chou R,
    2. Fanciullo GJ,
    3. Fine PG,
    4. et al
    . Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113–30.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. VonKorff M,
    2. Saunders K,
    3. Ray GT,
    4. et al
    . De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008;24:521–7.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Liu Y,
    2. Logan J,
    3. Paulozzi L,
    4. Zhang K,
    5. Jones C
    . Potential misuse and inappropriate prescription practices involving opioid analgesics. Am J Manag Care 2013;19:648–58.
    OpenUrlPubMed
  14. 14.↵
    1. Martin BC,
    2. Fan MY,
    3. Edlund MJ,
    4. Devries A,
    5. Braden JB,
    6. Sullivan MD
    . Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 2011;26:1450–7.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Kalso E,
    2. Edwards JE,
    3. Moore RA,
    4. McQuay HJ
    . Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372–80.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Noble M,
    2. Tregear S,
    3. Treadwell J,
    4. Shchoelles K
    . Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 2008;35:214–28.
    OpenUrlPubMedWeb of Science
  17. 17.↵
    1. Portenoy R,
    2. Farrar J,
    3. Backonja M,
    4. et al
    . Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain 2007;23:287–99.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Dunn KM,
    2. Saunders KW,
    3. Rutter CM,
    4. et al
    . Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010;152:85–92.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Logan J,
    2. Liu Y,
    3. Paulozzi L,
    4. Zhang K,
    5. Jones C
    . Opioid prescribing in emergency departments. Med Care 2013;51:646–53.
    OpenUrlPubMed
  20. 20.↵
    1. Campbell CI,
    2. Weisner C,
    3. LeResche L,
    4. et al
    . Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health 2010;100:2541–7.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Han H,
    2. Kass P,
    3. Wilsey B,
    4. Li C
    . Age, gender, and earlier opioid requirement associations with the rate of dose escalation in long-term opioid therapy. J Opioid Manage 2013;9:129–38.
    OpenUrl
  22. 22.↵
    1. Cepeda M,
    2. Etropolski M,
    3. Weinstein R,
    4. Fife D,
    5. Boston R,
    6. Matcho A
    . Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States. BMC Palliat Care 2010;9:14.
    OpenUrlPubMed
  23. 23.↵
    1. Tao XG,
    2. Lavin RA,
    3. Yuspeh L,
    4. Bernacki EJ
    . Natural history of opioid dosage escalation post-injury: a cohort study of injured workers in the State of Louisiana. J Occup Environ Med 2012;54:439–44.
    OpenUrlPubMed
  24. 24.↵
    1. Gustavsson A,
    2. Bjorkman J,
    3. Ljungcrantz C,
    4. Rhodin A,
    5. Rivano-Fischer M,
    6. Sjolund K
    . Pharmaceutical treatment patterns for patients with a diagnosis related to chronic pain initiating a slow-release strong opioid treatment in Sweden. Pain 2012;153:2325–31.
    OpenUrlPubMed
  25. 25.↵
    1. Cifuentes M,
    2. Webster B,
    3. Genevay S,
    4. Pransky G
    . The course of opioid prescribing for a new episode of disabling low back pain: opioid features and dose escalation. Pain 2010;151:22–9.
    OpenUrlPubMed
  26. 26.↵
    1. Schneider J,
    2. Kirsh K
    . Defining clinical issues around tolerance, hyperalgesia, and addiction: a quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice. J Opioid Manage 2010;6:385–95.
    OpenUrl
  27. 27.↵
    1. Franklin GM,
    2. Rahman EA,
    3. Turner JA,
    4. Daniell WE,
    5. Fulton-Kehoe D
    . Opioid use for chronic low back pain: a prospective, population-based study among injured workers in Washington state, 2002–2005. Clin J Pain 2009;25:743–51.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Braden JB,
    2. Sullivan MD,
    3. Ray GT,
    4. et al
    . Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry 2009;31:564–70.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Kelly JP,
    2. Cook SF,
    3. Kaufman DW,
    4. Anderson T,
    5. Rosenberg L,
    6. Mitchell AA
    . Prevalence and characteristics of opioid use in the US adult population. Pain 2008;138:507–13.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Sullivan MD,
    2. Edlund M,
    3. Steffick D,
    4. Unutzer J
    . Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005;119:95–103.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Sullivan MD,
    2. Edlund MJ,
    3. Zhang L,
    4. Unutzer J,
    5. Wells KB
    . Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006;166:2087–93.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Seal K,
    2. Shi Y,
    3. Cohen G,
    4. et al
    . Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012;307:940–7.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Saunders K,
    2. Von Korff M,
    3. Campbell CI,
    4. Banta-Green C,
    5. Sullivan M,
    6. Merrill JO
    . Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain 2012;3:266–75.
    OpenUrl
  34. 34.↵
    1. Hermos J,
    2. Young M,
    3. Gagon D,
    4. Fiore L
    . Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patients. Arch Int Med 2004;164:2361–6.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Washington State Department of Labor and Industries. Guidelines for prescribing opioids to treat pain in injured workers. Olympia, WA: Office of the Medical Director; 2013. Available from: http://www.lni.wa.gov/claimsins/Files/OMD/MedTreat/FINALOpioidGuideline010713.pdf. Accessed March 11, 2014.
  36. 36.↵
    1. Braden JB,
    2. Russo J,
    3. Fan MY,
    4. et al
    . Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170:1425–32.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Jones C
    . Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers–United States, 2002–2004 and 2008–2010. Drug Alcohol Depend 2013;132:95–100.
    OpenUrlPubMed
  38. 38.↵
    1. Paulozzi LJ,
    2. Kilbourne E,
    3. Shah N,
    4. et al
    . A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012;13:87–95.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Hall AJ,
    2. Logan JE,
    3. Toblin RL,
    4. et al
    . Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300:2613–20.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    Ohio Department of Health. Epidemic of prescription drug overdoses in Ohio, 2010. Available from: http://www.healthy.ohio.gov/vipp/data/∼/link.aspx?_id=16D12C012E474D0BA1670D47C1C71A44&_z=z. Accessed March 21, 2014.
  41. 41.↵
    1. LeMier M,
    2. Cummings P,
    3. West T
    . Accuracy of external cause of injury codes reported in Washington State hospital discharge records. Inj Prev 2001;7:334–8.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Blanc P,
    2. Jones M,
    3. Olson K
    . Surveillance of poisoning and drug overdose through hospital discharge coding, poison control center reporting, and the Drug Abuse Warning Network. Am J Emerg Med 1993;11:14–9.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Sullivan M,
    2. Edlund MJ,
    3. Fan M,
    4. DeVries A,
    5. Braden JB,
    6. Martin BC
    . Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain 2010;150:332–9.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Boscarino J,
    2. Rukstalis M,
    3. Hoffman S,
    4. et al
    . Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 2010;105:1776–82.
    OpenUrlCrossRefPubMed
  45. 45.↵
    Washington State Agency Medical Directors' Group. Interagency guideline on opioid dosing for chronic non-cancer pain. Available from: http://www.agencymeddirectors.wa.gov. Accessed March 11, 2014.
  46. 46.↵
    Chronic opioid therapy (COT) safety guideline for patients with chronic non-cancer pain. Seattle, WA: Group Health Cooperative; 2012. Available from: http://www.ghc.org/all-sites/guidelines/chronicOpioid.pdf. Accessed March 11, 2014.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords